Euromelanoma in Portugal 2010-2016

Filipa Duarte; Osvaldo Correia; João Nuno Maia e Silva; Cecília Moura; Ricardo Vieira; António Picoto

doi:10.29021/spdv.75.4.873

Filipa Duarte Associação Portuguesa de Cancro Cutâneo, Portugal; Centro de Dermatologia Epidermis, Instituto CUF, Porto, Portugal; Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Osvaldo Correia Associação Portuguesa de Cancro Cutâneo, Portugal; Centro de Dermatologia Epidermis, Instituto CUF, Porto, Portugal; Faculdade de Medicina da Universidade do Porto, Porto, Portugal
João Nuno Maia e Silva Associação Portuguesa de Cancro Cutâneo, Portugal; Clínica Universitária de Dermatologia, Faculdade de Medicina de Lisboa, Lisboa, Portugal; Centro de Dermatologia, Hospital CUF Descobertas, Lisboa, Portugal; Instituto CUF de Oncologia, Lisboa, Portugal
Cecília Moura Associação Portuguesa de Cancro Cutâneo, Portugal; Instituto Português de Oncologia, Lisboa, Portugal
Ricardo Vieira Associação Portuguesa de Cancro Cutâneo, Portugal; Serviço de Dermatologia do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal
António Picoto Associação Portuguesa de Cancro Cutâneo, Portugal; Clínica de Dermatologia Dr. António Picoto, Lisboa, Portugal

DOI: https://doi.org/10.29021/spdv.75.4.873

Keywords: Early Detection of Cancer, Health Promotion, Melanoma/ prevention & control, Skin Neoplasms/prevention & control

Abstract

Introduction: The incidence of skin cancer has been increasing in recent years around the world. Key targets in the fight against skin cancer include alerting populations to primary prevention by promoting knowledge about risk factors and encouraging better sun protection behaviors as well as secondary prevention promoting skin self-examination and screenings. The Portuguese Society of Dermatology and Venereology and the Portuguese Skin Cancer Association, have collaborated with Euromelanoma, a pan-European information and screening initiative for skin cancer since the year 2000.

Material and Methods: This cross-sectional study consisted in the evaluation of data from the completed Euromelanoma questionnaires during the Euromelanoma screening day in Continental Portugal and Islands, in public and private institutions from 2010 to 2016.

Results: A total of 9862 individuals were included, 63% female and 37% male, with a mean age of 48 years. The number of clinically suspected malignant or pre malignant lesions was relatively low but consistent with other published Euromelanoma studies: 3% basal cell carcinoma, 0.4% squamous cell carcinoma, 1% melanoma, and 6% of actinic keratoses.

Conclusion: The Euromelanoma initiative has raised at national and international level a greater awareness of the population on the theme of skin cancer, with promotion of the messages by the media, assuming itself as an important subject of public health, recognized by the political and sanitary authorities.

Downloads

Download data is not yet available.

References

US Preventive Services Task Force. Screening for skin cancer:

recommendations and rationale. Am J Prev Med.

; 20(3 Suppl):44-6.

Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli

G, Blasi PR. Screening for Skin Cancer in Adults:

Updated Evidence Report and Systematic Review for the

US Preventive Services Task Force. JAMA. 2016; 316:436-

Stratigos AJ, Forsea AM, van der Leest RJ, de Vries E, Nagore

E, Bulliard JL,et al. Euromelanoma: a dermatology-

-led European campaign against nonmelanoma skin

cancer and cutaneous melanoma. Past, present and future.

Br J Dermatol. 2012;167 Suppl 2:99-104.

Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert

R, Volkmer B, et al. Systematic skin cancer screening

in Northern Germany. J Am Acad Dermatol. 2012;

:201-11.

Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock

MA, Daniels S, et al. The first 15 years of the American

Academy of Dermatology skin cancer screening programs:

-1999. J Am Acad Dermatol. 2003; 48:34-41.

Dobbinson SJ, Wakefield MA, Jamsen KM, Herd NL, Spittal

MJ, Lipscomb JE, et al. Weekend sun protection and

sunburn in Australia trends (1987-2002) and association

with SunSmart television advertising. Am J Prev Med.

; 34:94-101.

Breitbart EW, Greinert R, Volkmer B. Effectiveness of information

campaigns. Prog Biophys Mol Biol. 2006; 92:167-

Greinert R, Boniol M. Skin cancer--primary and secondary

prevention (information campaigns and screening) - with

a focus on children & sunbeds. Prog Biophys Mol Biol.

; 107:473-6.

Amaro JA, Pecegueiro M, Quental A. Skin cancer screening

in a urban population. Skin Cancer. 1990; 5: 147-

Vandaele MM, Richert B, Van der Endt JD, Boyden B, Brochez

L, del Marmol V, et al. Melanoma screening: results

of the first one-day campaign in Belgium ('melanoma

Monday'). J Eur Acad Dermatol Venereol. 2000; 14:470-

Roche L, Foley CC, McCarthy S, Murphy M. The old reliables

outperform new media in social marketing of Euromelanoma

in Ireland: J Eur Acad Dermatol Venereol.

; 31:e296.

Correia O. A importância da prevenção primária do cancro

da pele. Acta Fotobiol. 2004; 19:19-24.

Correia O, Barros AM, Rocha N, et al. Skin cancer primary

prevention programme for school children. Analysis of

behavioral practices. Skin Cancer. 2006; 21:67-76.

Correia O, Barros AM, Quirino P, Rocha N, Ribeiro O,

Feijó A, Silva J, Pignatelli J, Pereira A. Skin cancer primary

prevention action in Portuguese beaches and analysis

of behaviour regarding sun exposure. Skin Cancer. 2007;

:7-19.

Correia O, Correia B, Duarte AF. A skin cancer prevention

campaign: spreading the word on sugar packets. JAMA

Dermatol. 2016 (in press).

Lim HW, Schneider SL. Sun safety practices-progress

made, more to go. JAMA Dermatol. 2017; 153:379-80.

Correia O, Duarte AF, Barros AM, Girão L, Picoto A. Muppies

as a way of skin cancer primary prevention. J Am

Acad Dermatol 2009: 60;AB94.

Mahon SM. Skin cancer prevention: education and public

health issues. Semin Oncol Nurs. 2003; 19:52-61.

Forsea AM, del Marmol V. Impact, challenges and perspectives

of Euromelanoma, a pan-European campaign

of skin cancer prevention: J Eur Acad Dermatol Venereol.

; 27:1317-9.

van der Leest RJ, de Vries E, Bulliard JL, Paoli J, Peris K,

Stratigos AJ, et al. The Euromelanoma skin cancer prevention

campaign in Europe: characteristics and results of

and 2010. J Eur Acad Dermatol Venereol. 2011;

:1455-65.

Stratigos A, Nikolaou V, Kedicoglou S, Antoniou C, Stefanaki

I, Haidemenos G, et al. Melanoma/skin cancer

screening in a Mediterranean country: results of the Euromelanoma

Screening Day Campaign in Greece. J Eur

Acad Dermatol Venereol. 2007; 21:56-62.

Koh HK, Geller AC, Miller DR, Caruso A, Gage I, Lew RA.

Who is being screened for melanoma/skin cancer? Characteristics

of persons screened in Massachusetts. J Am

Acad Dermatol. 1991; 24(2 Pt 1):271-7.

Suppa M, Altomare G, Cannavo SP, Capizzi R, Catricalà

C, Colombo E, et al. The Italian Euromelanoma Day: evaluation

of results and implications for future prevention

campaigns. Int J Dermatol. 2014;53:699-706.

Bulliard JL, Maspoli M, Panizzon RG, Hohl D, Gueissaz F,

Levi F. Evaluation of the Euromelanoma skin cancer screening

campaign: the Swiss experience. J Eur Acad Dermatol

Venereol. 2008; 22:365-66.

de Vries E, Coebergh JW. Melanoma incidence has risen

in Europe: BMJ. 2005; 331:698.

Del Marmol V, de Vries E, Roseeuw D, Pirard C, van der

Endt J, Trakatelli M, et al. A Prime minister managed to attract

elderly men in a Belgian Euromelanoma campaign.

Eur J Cancer. 2009; 45:1532-4.

Suppa M, Neri L, Bianchi L, Capizzi R, Carbone A, Catricalà

C, et al. The first skin cancer screening day at the

Italian parliament: a Euromelanoma initiative. Int J Dermatol.

; 54:42-9.

Paoli J, Danielsson M, Wennberg AM. Results of the 'Euromelanoma

Day' screening campaign in Sweden 2008. J

Eur Acad Dermatol Venereol. 2009; 23:1304-10.

Seidenari S, Benati E, Ponti G, Borsari S, Ferrari C, Albertini

G et al. Italian Euromelanoma Day Screening Campaign

(2005-2007) and the planning of melanoma screening

strategies. Eur J Cancer Prev. 2012; 21:89-95.

Diehl K, Litaker DG, Greinert R, Zimmermann S, Breitbart

EW, Schneider S. The prevalence of current sunbed use

and user characteristics: the SUN-Study 2008. Int J Public

Health. 2010; 55:513-6.

Duarte AF, Maia Silva JN, Costa Pereira A, Nagore E, Picoto

A, Correia O. Sunbed use among Portuguese beach

goers: a crave group while waiting sunbeds to be abolished.

J Eur Acad Dermatol Venereol. 2017; 31:e294-

-e295.

Autier P, Boniol M, Dore JF. Sunscreen use and increased

duration of intentional sun exposure: still a burning issue.

Int J Cancer. 2007; 121:1-5.

Thieden E, Philipsen PA, Sandby-Moller J, Wulf HC. Sunscreen

use related to UV exposure, age, sex, and occupation

based on personal dosimeter readings and sun-exposure

behavior diaries. Arch Dermatol. 2005; 141:967-73.

Gefeller O, Pfahlberg A. Sunscreen use and melanoma: a

case of evidence-based prevention? Photodermatol Photoimmunol

Photomed. 2002; 18:153-6.

Aviles-Izquierdo JA, Molina-Lopez I, Rodriguez-Lomba E,

Marquez-Rodas I, Suarez-Fernandez R, Lazaro-Ochaita P.

Who detects melanoma? Impact of detection patterns on

characteristics and prognosis of patients with melanoma.

J Am Acad Dermatol. 2016; 75:967-74.

Aitken JF, Elwood M, Baade PD, Youl P, English D. Clinical

whole-body skin examination reduces the incidence of

thick melanomas. Int J Cancer. 2010; 126:450-8.

Walton AE, Janda M, Youl PH, Baade P, Aitken JF, Whiteman

DC, et al. Uptake of skin self-examination and

clinical examination behavior by outdoor workers. Arch

Environ Occup Health. 2014; 69:214-22.

Duarte AF, Correia B, Picoto A, Costa Pereira A, Nagore E,

Correia O. Behaviour towards sun exposure, skin self-examination

and skin cancer knowledge of educators, health

professionals and the general population - cross-sectional

study: J Eur Acad Dermatol Venereol. 2017; 31:e132-

-e135.

Moreno Gimenez JC. The Euromelanoma Campaign:

Actas Dermosifiliogr. 2017; 108:389-91.

Duarte AF, da Costa-Pereira A, Del-Marmol V, Correia

O. Are General Physicians Prepared for Struggling Skin

Cancer?-Cross-Sectional Study. J Cancer Educ. 2016;

:13.

Badertscher N, Braun RP, Held U, Kofmehl R, Senn O, Hofbauer

GF, et al. Diagnostic competence of Swiss general

practitioners in skin cancer. Swiss Medical Wkly. 2013;

:13834.

Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken

J, Boniol M, et al. A nationwide population-based skin

cancer screening in Germany: proceedings of the first

meeting of the International Task Force on Skin Cancer

Screening and Prevention (September 24 and 25, 2009).

Cancer Epidemiol. 2010; 34:355-8.

Boniol M, Autier P, Gandini S. Melanoma mortality

following skin cancer screening in Germany. BMJ Open.

; 5:2015-008158.

Kaiser M, Schiller J, Schreckenberger C. The effectiveness

of a population-based skin cancer screening program:

evidence from Germany. Eur J Health Econ. 2017;

:017-0888.

Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact

of skin cancer screening and secondary prevention

campaigns on skin cancer incidence and mortality: A

systematic review. J Am Acad Dermatol. 2017; 76:129-

Grange F, Woronoff AS, Bera R, Colomb M, Lavole B,

Fournier E, et al. Efficacy of a general practitioner training

campaign for early detection of melanoma in France. Br J

Dermatol. 2014; 170:123-9.

Conejo-Mir J, Bravo J, Diaz-Perez JL, Fernández-Herrera J,

Guillén C, Martí R, et al. Dia del Euromelanoma. Resultados

en Espana de las campanas de 2000, 2001 y 2002.

Actas Dermo-Sifiliogr. 2005; 96:217-21.